Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is engaged in creating and developing novel medicines to address serious medical conditions.
$5.11
As of 04/09/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.